Michael John Wright
15Patents
5h-index
9Co-inventors
51Inventor score
Filing activity: May 28, 2015 → Aug 23, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10370447B2 | Molecules with specificity for CD79 and CD22 | Chemistry; Metallurgy | 13 | Active |
| US10358493B2 | Bispecific format suitable for use in high-through-put screening | Chemistry; Metallurgy | 13 | Active |
| US10590197B2 | Antibody molecules which bind CD22 | Chemistry; Metallurgy | 8 | Active |
| US10618979B2 | Multispecific antibodies | Chemistry; Metallurgy | 7 | Active |
| US10618957B2 | Antibody molecules which bind CD79 | Chemistry; Metallurgy | 7 | Active |
| US10774157B2 | Multispecific antibodies | Chemistry; Metallurgy | 5 | Active |
| US10774152B2 | Molecules with specificity for CD45 and CD79 | Chemistry; Metallurgy | 5 | Active |
| US10947304B2 | Gremlin-1 antibody | Chemistry; Metallurgy | 4 | Active |
| US11807680B2 | Gremlin-1 crystal structure and inhibitory antibody | Chemistry; Metallurgy | 2 | Active |
| US11261252B2 | Molecules with specificity for CD79 and CD22 | Chemistry; Metallurgy | 1 | Active |
| US11472879B2 | Antibody molecules which bind CD22 | Chemistry; Metallurgy | 1 | Active |
| US11286312B2 | Multispecific antibodies | Chemistry; Metallurgy | 0 | Active |
| US12331117B2 | Antibody molecules which bind CD22 | Chemistry; Metallurgy | 0 | Active |
| US10730952B2 | Molecules with specificity for CD45 and CD79 | General | 0 | Revoked |
| US11692041B2 | Antibody molecules which bind CD45 | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.